Christopher Gleeson is listed as a director on 1 SEC Form D filing by 1 issuer in Dec 2009: Osmetech PLC (Pasadena, CA — biotechnology — 2009; $8.55M reported sold to 21 investors).
What this means One deal on file with the SEC, filed Dec 2009. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Daryl J. Faulkner (1 shared filing), David Anthony Sandilands (1 shared filing) and Jon Faiz Kayyem (1 shared filing).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Christopher. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 bankruptcy cases matching the name listed in Key records below.
What this means 6 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 1 public filing for Christopher Gleeson and found 2 differences: Offering amount changed between filings; Reported revenue range changed between filings.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.